Salarius Pharmaceuticals
Stock Forecast, Prediction & Price Target
Salarius Pharmaceuticals Financial Estimates
Salarius Pharmaceuticals Revenue Estimates
Salarius Pharmaceuticals EBITDA Estimates
Salarius Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.84M N/A | $0 -100% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $11.87M Low: $11.87M High: $11.87M avg. 0% | ||
Net Income
% change YoY
| $-12.70M N/A | $-31.37M -146.96% | $-12.54K 99.96% | Avg: $-22.99M Low: $-9.58M High: $-9.58M avg. -183265.89% | Avg: $-828.40K Low: $-828.40K High: $-828.40K avg. 96.39% | ||
EBITDA
% change YoY
| $-12.85M N/A | $-14.11M -9.79% | $-2.84K 99.97% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $-2.37M Low: $-2.37M High: $-2.37M avg. 0% | ||
EPS
% change YoY
| -$7.68 N/A | -$14.77 -92.31% | -$0 99.97% | Avg: -$187.84 Low: -$187.84 High: -$187.84 avg. -4943057.89% | Avg: -$16.24 Low: -$16.24 High: -$16.24 avg. 91.35% | ||
Operating Expenses
% change YoY
| $14.65M N/A | $22.97M 56.79% | $12.89K -99.94% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $20.68M Low: $20.68M High: $20.68M avg. 0% | ||
FAQ
What is Salarius Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -91584.74% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -9.58M, average is -22.99M and high is -9.58M.
What is Salarius Pharmaceuticals stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Salarius Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -2471483.27% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$187.84, average is -$187.84 and high is $-187.84.